galantamine has been researched along with rs 67333 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guillou, C; Lamirault, L; Simon, H; Thal, C | 1 |
Boulouard, M; Dauphin, F; Freret, T; Hamidouche, K; Lecouflet, P; Lelong-Boulouard, V | 1 |
2 other study(ies) available for galantamine and rs 67333
Article | Year |
---|---|
Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats.
Topics: Age Factors; Aniline Compounds; Animals; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Injections, Intraperitoneal; Male; Memory; Pattern Recognition, Automated; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Task Performance and Analysis | 2003 |
Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.
Topics: Allosteric Regulation; Alzheimer Disease; Aniline Compounds; Animals; Cholinesterase Inhibitors; Galantamine; Male; Memory Disorders; Mice; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT4; Scopolamine; Serotonin 5-HT4 Receptor Agonists | 2017 |